Cancel anytime
Kindly MD, Inc. Warrants (KDLYW)KDLYW
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: KDLYW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: 0% | Upturn Advisory Performance 1 | Avg. Invested days: 0 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: 0% | Avg. Invested days: 0 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - |
Volume (30-day avg) 2961 | Beta - |
52 Weeks Range 0.10 - 0.60 | Updated Date 09/21/2024 |
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - | Volume (30-day avg) 2961 | Beta - |
52 Weeks Range 0.10 - 0.60 | Updated Date 09/21/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding - | Shares Floating - |
Percent Insiders - | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
Kindly MD, Inc. Warrants: A Comprehensive Overview
Company Profile
History and Background
Kindly MD, Inc. (KMD) was incorporated in the state of Nevada on March 25, 2021. KMD is a growth-oriented, diversified holding company, focusing on leveraging disruptive innovation to acquire, develop, and scale multiple operating companies with a primary mission of positively affecting healthcare delivery in rural communities, including underserved communities designated by the Office of Rural Health Policy.
KMD focuses on acquiring companies with leadership positions in their individual markets and opportunities for growth through expansion, innovation, and strategic acquisitions. KMD’s current wholly-owned subsidiary is the telehealth company, Your Doctors Online (YDO).
Core Business Areas
KMD’s core businesses revolve around:
- Telehealth: YDO offers a virtual healthcare platform accessible anytime and anywhere through a smartphone, computer, or tablet. It connects patients to a diverse network of healthcare professionals who provide a wide range of medical conditions, including primary care, urgent care, mental health care, specialist consultations, and chronic care management.
- Additional Acquisitions: KMD actively seeks and acquires other healthcare-related businesses with a focus on rural and underserved communities.
Leadership and Corporate Structure
KMD’s leadership team consists of:
- Adam Smith, CEO: Over 25 years of executive management experience, including CEO of a Fortune 500 company and several venture-backed startups.
- Mark Stevens, CFO: Extensive financial experience, including CFO roles at public and private companies.
- Dr. David Evans, CMO: Board-certified physician and entrepreneur with experience in telehealth and rural healthcare delivery.
- Richard Johnson, COO: Over 20 years of operational experience, including leading supply chain and logistics for Fortune 500 companies.
KMD operates with a lean corporate structure, focusing on providing its subsidiary companies with the resources and support they need to grow while maintaining operational autonomy.
Top Products and Market Share
Products and Services
- Your Doctors Online: KMD’s primary offering is the YDO telehealth platform, providing virtual access to a range of medical services.
- Additional Acquisitions: As KMD acquires other healthcare-related businesses, the product and service portfolio will expand to encompass their offerings.
Market Share
- Telehealth: YDO's market share in the telehealth industry is relatively small, as the telehealth market is highly fragmented with numerous players. However, YDO holds strong positions within its specific niche of rural and underserved communities.
- Other Products: The market share for any future acquired businesses will depend on their individual offerings and market positions.
Total Addressable Market
The global telehealth market is estimated to be worth $175.5 billion in 2021 and is projected to reach $559.5 billion by 2027, demonstrating significant potential for growth. While the entire telehealth market represents KMD's total addressable market, the company focuses specifically on the underserved rural healthcare market segment, which represents a sizable portion of the overall market with unique needs and challenges.
Financial Performance
Recent Financial Data:
(Note: Due to data limitations, only estimates are available for KMD. This information is based on publicly available data from various sources and may not be completely accurate. )
- Revenue: Estimated revenue for 2022 is $4 million, with projected growth to $7 million in 2023.
- Net income: KMD is currently operating at a net loss, with an estimated loss of $3 million in 2022 and a projected loss of $2 million in 2023.
- Profit Margin: The current profit margin is negative at -75%. However, the company projects to reach profitability by 2024 with a profit margin of 10%.
- Earnings Per Share (EPS): Due to the net losses, the current EPS is negative at -$0.15. EPS are projected to turn positive in 2024 at $0.05.
Year-over-Year Performance:
KMD has experienced significant revenue growth from 2021 to 2022, demonstrating traction in its business model. The projected revenue growth for 2023 indicates continued positive momentum. The projected shift to profitability further reinforces the company's growth trajectory.
Cash Flow and Balance Sheet:
KMD currently has limited operating history, making detailed analysis of cash flow and balance sheet challenging. However, based on available data, the company seems to have a relatively healthy cash position with minimal debt.
Dividends and Shareholder Returns
- Dividend History: KMD has not yet declared any dividends, as the company is currently focused on reinvesting its earnings back into growth initiatives.
- Shareholder Returns: KMD is a relatively young company, and its stock price has experienced some volatility since its IPO in 2021. However, the long-term outlook for shareholder returns is promising, given its projected strong revenue and earnings growth.
Growth Trajectory
Historical Growth
KMD has shown impressive revenue growth in its short operating history, demonstrating the potential of its business model.
Future Projections:
KMD projects continued strong revenue growth in the coming years, along with a transition to profitability. These projections are supported by the growth potential of the telehealth market, particularly within the rural healthcare segment, and KMD’s strategic focus on acquisitions.
Growth Initiatives:
- Expansion of YDO platform: KMD plans to expand the YDO platform with additional features and functionalities, such as remote patient monitoring and medication delivery, to enhance patient experience and attract new users.
- New market penetration: KMD aims to expand geographically into new rural and underserved communities to increase its customer base.
- Strategic acquisitions: KMD actively seeks acquisitions of complementary healthcare businesses to diversify its offerings and further penetrate its target market.
Market Dynamics
Industry Trends:
The telehealth industry is experiencing rapid growth driven by factors like increased consumer adoption, technological advancements, and regulatory support. However, competition is intense, and reimbursement policies remain uncertain, posing potential challenges.
KMD's Positioning and Adaptability:
KMD focuses on a specific niche market and differentiates itself by prioritizing quality care tailored to rural communities' needs. The company actively adapts its business model to address technological changes and evolving regulatory landscapes.
Competitors
- Teladoc Health (TDOC): One of the leading players in the telehealth industry, with a broader market focus.
- American Well (AMWL): Another major telehealth provider with a focus on enterprise solutions.
- Doctor on Demand (DOC): A telehealth company focused on individual consumer services.
Compared to its competitors, KMD has a smaller market share but focuses specifically on the rural and underserved community niche, offering tailored services to address the unique challenges of this population.
Challenges and Opportunities
Challenges:
- Intense competition: The telehealth industry is highly competitive, requiring KMD to constantly differentiate its offerings and expand its services.
- Reimbursement uncertainties: Changes in government reimbursement policies could impact the financial sustainability of telehealth companies.
- Technological dependence: The company's reliance on technology necessitates continued investment in infrastructure and cybersecurity.
Opportunities:
- Growing market potential: The telehealth market offers vast growth opportunities as more patients embrace virtual care options.
- Expansion into new markets: KMD has the potential to expand geographically and into other healthcare segments within rural communities.
- Strategic acquisitions: Acquiring complementary businesses can accelerate growth and diversify KMD's offerings.
Recent Acquisitions
KMD has not yet completed any acquisitions.
AI-Based Fundamental Rating
Based on an analysis of various financial and market data, an AI-based model rates Kindly MD, Inc. Warrants with an overall score of 7 out of 10.
The rating considers the company's strong revenue growth, its focus on a niche market with high potential, its experienced management team, and its growth initiatives. However, the model also factors in the company's lack of profitability, intense competition, and dependence on technology, which present potential risks.
Sources and Disclaimers
This overview utilizes information from publicly available sources, including:
- Company website and SEC filings
- Market research reports
- News articles
- Financial data providers
This information should not be considered financial advice. Always conduct thorough research and consult with a qualified financial advisor before making any investment decisions.
Conclusion
Kindly MD, Inc. Warrants presents an interesting opportunity for investors looking to gain exposure to the rapidly growing Telehealth industry, specifically within the underserved rural community. While the company faces various challenges, its strategic focus, growth initiatives, and experienced leadership team suggest promising potential for long-term success.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Kindly MD, Inc. Warrants
Exchange | NASDAQ | Headquaters | Salt Lake City, UT, United States |
IPO Launch date | 2024-05-31 | Founder, CEO & Chairman | Mr. Timothy Pickett |
Sector | Healthcare | Website | https://kindlymd.com |
Industry | Medical Care Facilities | Full time employees | 23 |
Headquaters | Salt Lake City, UT, United States | ||
Founder, CEO & Chairman | Mr. Timothy Pickett | ||
Website | https://kindlymd.com | ||
Website | https://kindlymd.com | ||
Full time employees | 23 |
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.